<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prevalence of symptoms in 34 Omani patients with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) was: <z:e sem="disease" ids="C0554021" disease_type="Disease or Syndrome" abbrv="">recurrent oral ulceration</z:e> 100%, <z:hpo ids='HP_0001369'>arthritis</z:hpo>/<z:hpo ids='HP_0002829'>arthralgia</z:hpo> and <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulceration</z:e> 74% each, <z:mp ids='MP_0000376'>folliculitis</z:mp> 64%, neurological lesions 62%, <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> 30%, <z:hpo ids='HP_0001101'>iritis</z:hpo> and <z:e sem="disease" ids="C0020641" disease_type="Disease or Syndrome" abbrv="">hypopyon</z:e> 26%, gastrointestinal lesions 12%, <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and cardiovascular lesions 9% each, and pleuropulmonary lesions and <z:hpo ids='HP_0000031'>epididymitis</z:hpo> 6% each </plain></SENT>
<SENT sid="1" pm="."><plain>Antiphospholipid (APL) antibodies (both anticardiolipin [ACAs] and anti-beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I [abeta2GPIs]) were present in 11/34 (32%) of the BD patients and in 54/73 (74%) of Omani patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) (chi2 = 21.2, P&lt;0.001) </plain></SENT>
<SENT sid="2" pm="."><plain>In patients possessing APL antibodies, there was no significant difference in mean antibody levels between BD and SLE patients </plain></SENT>
<SENT sid="3" pm="."><plain>IgM isotype antibodies, in the absence of IgG, were more prevalent in BD (5/11) than in SLE (10/54) patients (chi2 =3.8, P = 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The frequency of organ involvement was similar in patients with and without APL antibodies (chi2 = 1.226, P &gt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>This study fails to demonstrate a pathognomonic role for APL antibodies in BD </plain></SENT>
</text></document>